Literature DB >> 24013068

The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Lisi Amsler1, Marieke Verweij1, Victor R DeFilippis1.   

Abstract

Human cytomegalovirus (HCMV) is a member of the β-herpesvirus family that invariably occupies hosts for life despite a consistent multi-pronged antiviral immune response that targets the infection. This persistence is enabled by the large viral genome that encodes factors conferring a wide assortment of sophisticated, often redundant phenotypes that disable or otherwise manipulate impactful immune effector processes. The type I interferon system represents a first line of host defense against infecting viruses. The physiological reactions induced by secreted interferon act to effectively block replication of a broad spectrum of virus types, including HCMV. As such, the virus must exhibit counteractive mechanisms to these responses that involve their inhibition, tolerance, or re-purposing. The goal of this review is to describe the impact of the type I interferon system on HCMV replication and to showcase the number and diversity of strategies employed by the virus that allow infection of hosts in the presence of interferon-dependent activity.
© 2013.

Entities:  

Keywords:  COX2; HCMV; HIV; HSV; Herpes Simplex virus; IFI16; IFN promoter stimulator 1; IFN regulatory factor; IFN-stimulated gene; IFNγ-inducible protein 16; IPS1; IRF; ISG; MCMV; NFκB; NK; ORF; PKR; PML; PRR; RIG-I; cyclooxygenase 2; cytomegalovirus; double-stranded DNA; double-stranded RNA; dsDNA; dsRNA; human cytomegalovirus; human immunodeficiency virus; immune evasion; innate immunity; interferon; murine cytomegalovirus; natural killer; nuclear factor κB; open reading frame; pattern recognition receptor; promyelocytic leukemia; protein kinase R; retinoic acid-inducible gene I

Mesh:

Substances:

Year:  2013        PMID: 24013068      PMCID: PMC3864659          DOI: 10.1016/j.jmb.2013.08.023

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  160 in total

1.  Identification and characterization of human cytomegalovirus-encoded microRNAs.

Authors:  Finn Grey; Andy Antoniewicz; Edwards Allen; Julie Saugstad; Andy McShea; James C Carrington; Jay Nelson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection.

Authors:  Victor R DeFilippis; Bridget Robinson; Thomas M Keck; Scott G Hansen; Jay A Nelson; Klaus J Früh
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression.

Authors:  R Travis Taylor; Wade A Bresnahan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

5.  CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection.

Authors:  Espen Ø Kvale; Jakob Dalgaard; Fridtjof Lund-Johansen; Halvor Rollag; Lorant Farkas; Karsten Midtvedt; Frode L Jahnsen; Jan E Brinchmann; Johanna Olweus
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

6.  A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.

Authors:  Christina Paulus; Steffen Krauss; Michael Nevels
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-23       Impact factor: 11.205

Review 7.  Antiviral innate immunity pathways.

Authors:  Rashu B Seth; Lijun Sun; Zhijian J Chen
Journal:  Cell Res       Date:  2006-02       Impact factor: 25.617

8.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

9.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

10.  Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma.

Authors:  Bruno Sainz; Heather L LaMarca; Robert F Garry; Cindy A Morris
Journal:  Virol J       Date:  2005-02-23       Impact factor: 4.099

View more
  29 in total

Review 1.  Manipulation of host pathways by human cytomegalovirus: insights from genome-wide studies.

Authors:  Yifat Cohen; Noam Stern-Ginossar
Journal:  Semin Immunopathol       Date:  2014-09-27       Impact factor: 9.623

Review 2.  Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.

Authors:  Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2016-08-12       Impact factor: 3.402

Review 3.  Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.

Authors:  Marni S Crow; Krystal K Lum; Xinlei Sheng; Bokai Song; Ileana M Cristea
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

4.  WDR5 Facilitates Human Cytomegalovirus Replication by Promoting Capsid Nuclear Egress.

Authors:  Bo Yang; Xi-Juan Liu; Yongxuan Yao; Xuan Jiang; Xian-Zhang Wang; Hong Yang; Jin-Yan Sun; Yun Miao; Wei Wang; Zhen-Li Huang; Yanyi Wang; Qiyi Tang; Simon Rayner; William J Britt; Michael A McVoy; Min-Hua Luo; Fei Zhao
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Authors:  Vanessa M Noriega; Kester K Haye; Thomas A Kraus; Shanna R Kowalsky; Yongchao Ge; Thomas M Moran; Domenico Tortorella
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 6.  The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Authors:  Mark R Wills; Emma Poole; Betty Lau; Ben Krishna; John H Sinclair
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

7.  Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.

Authors:  Maorong Xie; Baoqin Xuan; Jiaoyu Shan; Deng Pan; Yamei Sun; Zhao Shan; Jinping Zhang; Dong Yu; Bin Li; Zhikang Qian
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

8.  Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.

Authors:  Yu-Zhi Fu; Shan Su; Hong-Mei Zou; Yi Guo; Su-Yun Wang; Shu Li; Min-Hua Luo; Yan-Yi Wang
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

9.  Antiviral innate immunity: editorial overview.

Authors:  Eric O Freed; Michael Gale
Journal:  J Mol Biol       Date:  2014-01-22       Impact factor: 5.469

10.  Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response.

Authors:  Thomas Harwardt; Simone Lukas; Marion Zenger; Tobias Reitberger; Daniela Danzer; Theresa Übner; Diane C Munday; Michael Nevels; Christina Paulus
Journal:  PLoS Pathog       Date:  2016-07-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.